• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    The Food and Drug Administration approved Repatha Thursday, for two groups of patients who are unable to control their cholesterol with existing drugs and treatments. (Amgen Inc. via AP)
    Healthcare

    FDA approves another game-changing cholesterol drug

    Robert King -
    August 28, 2015 1:52 pm
    0
    A medical worker shows capsules as he works at the Middle East Company for Pharmaceutical Industries September 08, 2008 in Bait Hanoun, Gaza Strip. (Photo by Abid Katib/Getty Images)
    Economy

    New international trade deal must include robust drug rights

    Andrew Langer -
    August 27, 2015 4:01 am
    0
    In July, the FDA announced it intends to require four types of quality metrics from pharmaceutical manufacturers and three optional ones. It held a meeting to get industry feedback on the metrics on Monday. (AP Photo/Gregory Bull)
    Healthcare

    Government wants to grade drugmakers, but keep grades secret

    Robert King -
    August 25, 2015 4:01 am
    0
    In this Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite. (AP Photo/Allen G. Breed)
    Healthcare

    OK for female sex drug follows patient-centered trend

    Robert King -
    August 23, 2015 4:01 am
    0
    In 2009, the manufacturer of Zicam voluntarily recalled nasal products using zinc in the drug after consumers claimed they lost their ability to smell. (Getty)
    Healthcare

    Overhaul of rules for homeopathic drugs wanted

    Robert King -
    August 21, 2015 8:44 pm
    0
    A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals. Valeant Pharmaceuticals will acquire Sprout Pharmaceuticals for about $1 billion. (AP Photo/Allen G. Breed)
    Healthcare

    Female libido drug maker to be sold

    Robert King -
    August 20, 2015 12:14 pm
    0
    Obamacare supporters and protesters gather in front of the U.S. Supreme Court to find out the ruling on the Affordable Health Act June 28, 2012 in front of the U.S. Supreme Court in Washington, D.C. (Photo by Alex Wong/Getty Images)
    Healthcare

    Poll: Americans split on Obamacare but agreed on prescription drug policies

    Paige Winfield Cunningham -
    August 20, 2015 7:00 am
    0
    Sprout Pharmaceuticals CEO Cindy Whitehead holds a bottle for the female sex-drive drug Addyi. After two rejections, the U.S. Food and Drug Administration gave approval Tuesday for the drug as a treatment for hypoactive sexual desire disorder, a first for women. (AP Photo/Allen G. Breed)
    Healthcare

    Female libido drug won’t be marketed on TV

    Robert King -
    August 19, 2015 3:11 pm
    0
    Women with reduced sexual desire would benefit from a libido-enhancing drug, the FDA wrote, but then stressed that benefits must outweigh side effects before it will approve flibanserin. (AP Photo) 
    Healthcare

    FDA approves female ‘Viagra’

    Robert King -
    August 18, 2015 11:17 pm
    0
    Women with reduced sexual desire would benefit from a libido-enhancing drug, the FDA wrote, but then stressed that benefits must outweigh side effects before it will approve flibanserin. (AP Photo) 
    Healthcare

    FDA to rule on female ‘Viagra’

    Robert King -
    August 18, 2015 4:01 am
    0
    1...138139140...158Page 139 of 158
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.